Cancer therapy: can the challenge be MET?

This publication has 66 references indexed in Scilit:

• RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and Survival
  Cancer Research, 2004
• The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants
  Oncogene, 2004
• Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4
  The Journal of Gene Medicine, 2004
• Antisense oligonucleotide-based therapeutics for cancer
  Oncogene, 2003
• The Semaphorin 4D receptor controls invasive growth by coupling with Met
  Nature Cell Biology, 2002
• Scatter-factor and semaphorin receptors: cell signalling for invasive growth
  Nature Reviews Cancer, 2002
• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
  New England Journal of Medicine, 2002
• A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
  Cell, 2001
• Cooperative Signaling between α6β4Integrin and ErbB-2 Receptor Is Required to Promote Phosphatidylinositol 3-Kinase-dependent Invasion
  Journal of Biological Chemistry, 2000
• Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.
  The Journal of cell biology, 1993